← Eichor
Study identifier: NCT07198594 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder

Condition: Obsessive Compulsive Disorder (OCD) · Obsessive - Compulsive Disorder  ·  Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if individualized accelerated repetitive transcranial magnetic stimulation (rTMS) targeting the inferior frontal cortex combined with symptom provocation works to treat obsessive-compulsive disorders (OCD) in adults. It will also learn about the safety of rTMS over right IFC. The main questions it aims to answer are: * Does rTMS using a new individualized IFC target relieve participants' OCD symptoms? * What medical problems do participants have when taking rTMS? Participants will: * Take rTMS six times per day for 5 consecutive days * Visit the clinic once at baseline, the day and four weeks after treatment for checkups and tests

This description comes directly from the study's public registry record.

Talk to the study team

Yijie Zhao  ·  +86 13585960699  ·  yj_zhao@tongji.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Pudong New Area Mental Health CentreShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07198594